Strategic Swiss Partners AG,

Bahnhofstrasse 10 / Börsenstrasse 18, 8001 Zürich  SWITZERLAND

info@strategicswisspartners.com  |   +41 44 980 8000 

Copyright   ©   Strategic Swiss Partners AG 2019

News

January 21, 2020

Langenfeld, Germany, 4. January 2020

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), announced the acquisition of S.T.U. GmbH (Swiss Trade Union or S.T.U.), a leading Switzerland-based developer and distributor of natural cannabidiol (CBD) consumer products. The deal enables Neuraxpharm to enter the fast-growing...

Please reload

Featured Posts

SSP concludes Neuraxpharm acquisition of Swiss-based S.T.U. GmbH - CBD brand Hemplix™

January 21, 2020

1/10
Please reload

Recent Posts
Please reload

Archive
Please reload

Follow Us